TY  - JOUR
AU  - Sanz, Laura
AU  - Cuesta Martínez, Ángel
AU  - Compte, Marta
AU  - Álvarez Vallina, Luis
PY  - 2005
DO  - 10.1111/j.1745-7254.2005.00135.x
SN  - 1671-4083
SN  - 1745-7254
UR  - https://hdl.handle.net/20.500.14352/114669
T2  - Acta Pharmacol Sin
AB  - Antibody-based therapeutics are beginning to realize the promise enclosed in their early denomination as magic bullets. Initial disappointment has turned into clinical and commercial success, and engineered antibodies currently represent over 30% of...
LA  - eng
M2  - 641
PB  - Nature
KW  - immunoglobulin fragments
KW  - monoclonal antibodies
KW  - antibody formation
KW  - gene therapy
KW  - recombinant proteins
KW  - biomedical engineering
TI  - Antibody engineering: facing new challenges in cancer therapy
TY  - journal article
VL  - 26
ER  -